Alignment on the Sell Side: Understanding different types of buyers

William L. (Bill) serves as executive vice president and co-head of Capital Markets. He is responsible for assisting with the strategic direction of the Capital Markets division as well as driving the Bank’s growth in strategic merger and acquisition advisory services, equity origination and financial sponsors business. He also is responsible for driving the Bank’s capital market non-organic growth strategy.

Bill joined the Bank in 2016 after 18 years with BB&T, where he most recently served as senior managing director and co-head of investment banking for BB&T Capital Markets and a predecessor, Scott & Stringfellow. Before that he was a managing director at Wheat First Butcher Singer. Through his career in investment banking and capital markets, he has completed more than 150 capital financing and M&A advisory assignments.

Education
Bill earned a bachelor’s degree in finance and accounting from the McIntire School of Commerce at the University of Virginia and later graduated from The Executive Program at the Darden Graduate School of Business Administration.

Professional and Civic
Bill serves on multiple boards for the University of Virginia, including serving as past president of the Virginia Athletics Foundation Board of Trustees and of the McIntire School of Commerce Advisory Board. He also is former chairman of the St. Margaret’s School Board of Governors and serves on the finance committee of the Church Schools of the Diocese of Virginia. Bill is a founding member of the RVA 100, a youth philanthropic organization in Richmond, Virginia, that has raised over $300,000 for children in need in Central Virginia.

David Dill is president and CEO of LifePoint Health. In this role, he is responsible for the development and oversight of LifePoint’s strategic priorities and organizational growth, advancing the company's mission and strengthening its culture enterprise-wide. He joined LifePoint in 2007 as executive vice president and CFO before serving in his most recent role as president and COO from 2009 to 2018. Under his leadership, the company has expanded its footprint to 89 hospital campuses, with revenue growing from $3 billion in 2009 to more than $8 billion in 2018, and enhanced its focus on quality and patient safety.

John Fuller advises clients in complex corporate transactions, including representing private equity and venture funds as well as portfolio companies in M&A transactions, joint ventures, business formation and other strategic investment transactions. His clients range from established public and private companies to emerging start-ups across a range of industries including food & beverage, retail, healthcare, sports, media, and technology. John has counseled clients on more than $1 billion in M&A and VC financing transactions.

Anna Kovalkova is a partner at Pharos Capital Group. She is responsible for leading the evaluation, due diligence and execution of investments as well as oversight of portfolio companies. She is a member of the investment committees of Pharos' funds and currently serves on the boards of Beacon Specialized Living, Charter Healthcare Group, Complete Healthcare Partners, Seaside Healthcare, Sona Dermatology and MedSpa, TotalTrax, and Verdi Oncology.

William Seibels is the Chief Financial Officer of IVX Health, where his responsibilities include finance & accounting, legal, revenue cycle, and operations. He joined IVX Health in January 2018, having previously served as SVP Finance for Change Healthcare (formerly Emdeon). His prior experience includes CFO of a venture-backed healthcare Software as a Service company and SVP Operations for a multi-state, private equity backed home healthcare company. He started his career in investment banking, and holds bachelor’s degrees in English and business administration from The University of Mississippi and a master’s degree in business administration from the Harvard Business School.